Showing results (261-270 of 287) with videos related to
Sort By:
Pageof 29
The Journal of Dermatology|October 11, 2019
Clinical practice guidelines for the management of atopic dermatitis 2018Norito Katoh, Yukihiro Ohya, Masanori Ikeda, et al.Allergology International : Official Journal of the Japanese Society of Allergology|April 9, 2020
Japanese guidelines for atopic dermatitis 2020Norito Katoh, Yukihiro Ohya, Masanori Ikeda, et al.The Journal of Dermatology|February 28, 2013
Guidelines for the diagnosis and treatment of vitiligo in JapanNaoki Oiso, Tamio Suzuki, Mari Wataya-Kaneda, et al.Cancer Immunology Research|February 25, 2018
Identification of Tumoricidal TCRs from Tumor-Infiltrating Lymphocytes by Single-Cell AnalysisKiyomi Shitaoka, Hiroshi Hamana, Hiroyuki Kishi, et al.Proceedings of the National Academy of Sciences of the United States of America|April 6, 2011
PDGFRalpha-positive cells in bone marrow are mobilized by high mobility group box 1 (HMGB1) to regenerate injured epitheliaKatsuto Tamai, Takehiko Yamazaki, Takenao Chino, et al.The Journal of Dermatology|June 1, 2026
Second Guidelines for the Diagnosis and Treatment of Vitiligo in Japan (2025)Atsushi Tanemura, Naoki Oiso, Ken Okamura, et al.Proceedings of the National Academy of Sciences of the United States of America|November 2, 2011
Characterization of dsRNA-induced pancreatitis model reveals the regulatory role of IFN regulatory factor 2 (Irf2) in trypsinogen5 gene transcriptionHideki Hayashi, Tomoko Kohno, Kiyoshi Yasui, et al.Experimental Dermatology|April 19, 2012
Periostin, a matricellular protein, accelerates cutaneous wound repair by activating dermal fibroblastsKanako Ontsuka, Yorihisa Kotobuki, Hiroshi Shiraishi, et al.The American Journal of Pathology|October 10, 2009
Nodal lymphangiogenesis and metastasis: Role of tumor-induced lymphatic vessel activation in extramammary Paget's diseaseSatoshi Hirakawa, Michael Detmar, Dontscho Kerjaschki, et al.Journal of Autoimmunity|December 13, 2021
Cell surface-expressed Ro52/IgG/HLA-DR complex is targeted by autoantibodies in patients with inflammatory myopathiesNoriko Arase, Hideaki Tsuji, Hyota Takamatsu, et al.Pageof 29